SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-008420
Filing Date
2024-01-30
Accepted
2024-01-30 20:41:24
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244628-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244628-4_4seq1.xml 4 6248
  Complete submission text file 0001104659-24-008420.txt   7838
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
O'Mahony John Mark (Reporting) CIK: 0001808556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 24580329